Market Data

This information is collected under the Access to Cannabis for Medical Purposes Regulations, which replaced the Marihuana for Medical Purposes Regulations on August 24, 2016.

Based on market data, there is overall sufficient supply of cannabis for medical purposes to meet the current needs of registered clients. 

Notice of reporting changes:

As part of a continual effort to improve data collection, Health Canada clarified reporting requirements for licensed producers in October 2016. Licensed producers have been asked to report on the amount of cannabis for medical purposes that they have released for sale to clients. This amount is to include only product that has been approved for sale to clients (e.g., tested and ready for sale), which may have been produced in either the current or a previous reporting period. As such, this amount is to exclude product that was produced during the current reporting period and not yet approved for sale (e.g., not yet tested and ready for sale).

This reporting change, beginning with data in Q3 2016-17, allows for a more accurate picture of the volume of supply that is available to registered clients; and, more consistent period-over-period analysis. It also aligns more closely with the inventory tracking practices of the licensed producers. Note: the change does not allow for a direct comparison with previous reporting periods.

In Q3, Health Canada also began to report on the number of active registration certificates issued to persons that are authorized to produce a limited amount of cannabis for their own medical purposes, or who have been designated to produce for another person.

As a continuation of our improvements to data reporting, in the first quarter (Q1) of fiscal year 2017-18 Health Canada began to report:

  • The total number of client shipments per month by province of residence; and
  • The total number of medical practitioners per month that provided a medical document for a client who registered with a licensed producer

In addition, in Q1 Health Canada began reporting monthly breakdowns for:

  • Dried marijuana sales, amounts released for sale, inventory; and
  • Cannabis oil sales, amounts released for sale, inventory.

Finally, in Q1 Health Canada began reporting the following information by province of residence:

  • Total number of client registrations with a licensed producer at end of month;
  • Total number of active registrations for personal and/or designated production at end of month;
  • Total number of personal producers at end of month; and
  • Total number of designated producers at end of month.
Cannabis for Medical Purposes (FY 2017-18) - Licensed Producers: Monthly Data
  Q1 Q2 Q3 Q4
  Apr. May Jun. Jul. Aug. Sept. Oct. Nov. Dec. Jan. Feb. Mar.
Dried Marijuana
Amount sold to clients (kilograms) 1,921 2,081 1,894                  
Amount released for sale to clients (kilograms)Table 5 Footnote 1 1,947 3,773 3,468                  
Total amount in licensed producers' inventories at end of month (kilograms)Table 5 Footnote 2 20,964 22,682 25,077                  
Cannabis Oil
Amount sold to clients (kilograms) 1,918 2,165 2,111                  
Amount released for sale to clients (kilograms)Table 5 Footnote 3 2,161 1,718 2,309                  
Total amount in licensed producers' inventories at end of month (kilograms)Table 5 Footnote 4 5,142 5,381 6,713                  
Total number of client registrations at end of monthTable 5 Footnote 5:
Canada 174,503 188,200 201,398                  
Alberta 60,479 68,055 74,013                  
British Columbia 7,454 7,756 8,103                  
Manitoba 2,987 3,325 3,598                  
New Brunswick 5,284 5,511 5,748                  
Newfoundland and Labrador 1,853 2,027 2,162                  
Northwest Territories 112 123 125                  
Nova Scotia 7,685 8,087 8,737                  
Nunavut 47 45 46                  
Ontario 77,692 81,522 86,196                  
Prince Edward Island 739 782 831                  
Quebec 5,149 5,330 5,630                  
Saskatchewan 4,937 5,535 6,108                  
Yukon 85 102 101                  
Total number of shipments to registered clients during month:
Canada 86,985 102,034 103,270                  
Alberta 30,103 33,970 33,889                  
British Columbia 2,876 3,332 3,278                  
Manitoba 1,462 1,774 1,827                  
New Brunswick 2,902 2,991 2,787                  
Newfoundland and Labrador 1,204 1,432 1,366                  
Northwest Territories 76 101 91                  
Nova Scotia 3,467 3,829 3,932                  
Nunavut 30 40 38                  
Ontario 39,165 47,746 49,159                  
Prince Edward Island 456 537 533                  
Quebec 2,790 3,452 3,417                  
Saskatchewan 2,407 2,776 2,901                  
Yukon 47 54 52                  
Health Care Practitioners
Medical practitioners that provided a medical document for a client who registered with an LP in the reporting period 2,359 2,314 2,786                  
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Table 5 Footnote 6 2.3 2.3 2.3                  
Table 5 Footnote 1

This refers to the amount of dried marijuana that was made available for sale to registered clients during each month (expressed in kg of dried marijuana). Production data was reported in this manner starting in October 2016.

Return to table 5 footnote 1 referrer

Table 5 Footnote 2

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each month. This may include dried marijuana that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); (3) is intended for extraction activities; or (4) is being held as samples.

Return to table 5 footnote 2 referrer

Table 5 Footnote 3

This refers to the amount of cannabis oil that was made available for sale to registered clients during each month (expressed in kg of cannabis oil). Production data was reported in this manner starting in October 2016.

Return to table 5 footnote 3 referrer

Table 5 Footnote 4

Changes in inventories may be a result of amounts of cannabis oil sold, produced, destroyed and imported.

Inventory refers to all cannabis oil held in stock at the end of each month. This may include cannabis oil that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); or (3) is being held as samples.

Return to table 5 footnote 4 referrer

Table 5 Footnote 5

This refers to the number of active client registrations with licensed producers at the end of each month. Individuals may be registered with more than one licensed producer provided an original medical document was used with each registration. Clients of licensed producers may also be registered with Health Canada to produce a limited amount of cannabis for their own medical purposes or to designate someone to produce it for them.

Return to table 5 footnote 5 referrer

Table 5 Footnote 6

The ACMPR requires that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana ("the equivalency factor"). Information about the equivalency factor is available on each licensed producer's website.

Return to table 5 footnote 6 referrer

Cannabis for Medical Purposes (FY 2017-18) - Personal and Designated Production: Monthly Data
  Q1 Q2 Q3 Q4
  Apr. May Jun. Jul. Aug. Sept. Oct. Nov. Dec. Jan. Feb. Mar.
Number of Active Registrations (as of the last day of the reporting period)
Canada 4,480 5,212 6,880                  
Alberta 419 468 629                  
British Columbia 1,489 1,720 2,201                  
Manitoba 95 140 184                  
New Brunswick 164 194 259                  
Newfoundland and Labrador 24 30 38                  
Northwest Territories 4 4 4                  
Nova Scotia 205 232 281                  
Nunavut 0 0 0                  
Ontario 1,641 1,923 2,590                  
Prince Edward Island 11 12 14                  
Quebec 277 329 487                  
Saskatchewan 150 158 191                  
Yukon 1 2 2                  
Production for Own Medical Purposes
Canada 4,148 4,822 6,374                  
Alberta 406 449 598                  
British Columbia 1,357 1,565 2,002                  
Manitoba 91 134 175                  
New Brunswick 154 183 244                  
Newfoundland and Labrador 23 28 36                  
Northwest Territories 4 4 4                  
Nova Scotia 185 210 257                  
Nunavut 0 0 0                  
Ontario 1,538 1,800 2,433                  
Prince Edward Island 11 12 14                  
Quebec 236 286 427                  
Saskatchewan 142 149 182                  
Yukon 1 2 2                  
Production by Designated Person
Canada 332 390 506                  
Alberta 13 19 31                  
British Columbia 132 155 199                  
Manitoba 4 6 9                  
New Brunswick 10 11 15                  
Newfoundland and Labrador 1 2 2                  
Northwest Territories 0 0 0                  
Nova Scotia 20 22 24                  
Nunavut 0 0 0                  
Ontario 103 123 157                  
Prince Edward Island 0 0 0                  
Quebec 41 43 60                  
Saskatchewan 8 9 9                  
Yukon 0 0 0                  
Cannabis for Medical Purposes (FY 2016-17) - Licensed Producers: Quarterly Data
  April 1, 2016 to June 30, 2016 (Q1) July 1, 2016 to September 30, 2016 (Q2) October 1, 2016 to December 31, 2016 (Q3) January 1, 2017 to March 31, 2017 (Q4)
Dried Marijuana
Amount sold to clients (kilograms) 4,037 4,773 5,134  5,836
Amount produced (kilograms) 5,014 5,734 N/A N/A
Amount released for sale to clients (kilograms) N/A N/A 4,577  5,674 
Amount in licensed producers' inventories at end of month (kilograms)Table 1 Footnote 1 11,788 13,246 18,087 18,140
Cannabis Oil
Amount sold to clients (kilograms) 1,500 2,420 4,109  5,673 
Amount produced (kilograms) 1,654 3,116 N/A  N/A
Amount released for sale to clients (kilograms) N/A N/A 3,975 5,298
Amount in licensed producers' inventories at end of month (kilograms)Table 1 Footnote 2 2,038 3,330 3,724  5,198 
Client Data
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Table 1 Footnote 3 2.7 2.6 2.5 2.4
Average amount of marijuana for medical purposes per client shipment (grams/day) 0.96 0.89 0.79 0.75
Total number of clients registered at end of quarter 75,166 98,460 129,876  167,754
Table 1 Footnote 1

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); (3) is intended for extraction activities; or (4) is being held as samples. Companies may only keep inventory up to the maximum capacity allowed by their licence.

Return to table 1 footnote 1 referrer

Table 1 Footnote 2

Changes in inventories may be a result of amounts of cannabis oil sold, produced, destroyed and imported.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) is intended for sale, but has not yet been tested/approved; (2) is approved for sale (has been tested and is ready for sale); or (3) is being held as samples. Companies may only keep inventory up to the maximum capacity allowed by their licence.

Return to table 1 footnote 2 referrer

Table 1 Footnote 3

The MMPR required that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. This remains a requirement under the ACMPR. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana ("the equivalency factor"). Information about the equivalency factor is available on each licensed producer's website.

Return to table 1 footnote 3 referrer

Cannabis for Medical Purposes (FY 2016-17) - Personal and Designated Production: Quarterly Data
  April 1, 2016 to June 30, 2016 (Q1) July 1, 2016 to September 30, 2016 (Q2) October 1, 2016 to December 31, 2016 (Q3) January 1, 2017 to March 31, 2017 (Q4)
Number of Active Registrations
(as of the last day of the reporting period)
Total N/A 192 2,007  3,422
Production for Own Medical Purposes N/A 189 1,899 3,186
Production by Designated Person N/A 3 108  236
2015 - 2016 Fiscal Year
  April 1, 2015 to June 30, 2015 (Q1) July 1, 2015 to September 30, 2015 (Q2) October 1, 2015 to December 31, 2015 (Q3) January 1, 2016 to March 31, 2016 (Q4)
Dried Marijuana
Amount sold to clients (kilograms) 1,371 1,873 2,481 3,082
Amount produced (kilograms)Table 3 Footnote 1 1,867 2,142 2,684 4,037
Amount in licensed producers' inventories at end of quarter (kilograms)Table 3 Footnote 2 5,445 7,312 9,729 10,695
Cannabis Oil
Amount sold to clients (kilograms) N/A N/A Table 3 Footnote 3 584
Amount produced (kilograms)Table 3 Footnote 4 N/A 9 128 892
Amount in licensed producers' inventories at end of quarter (kilograms)Table 3 Footnote 5 N/A 7 208 1,421
Client Data
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Table 3 Footnote 6 3.3 3.0 2.9 2.8
Average amount of marijuana for medical purposes per client shipment (grams/day) 1.08 1.12 1.12 1.03
Total number of clients registered at end of quarter 23,930 30,537 39,668 53,649
Table 3 Footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana).

Return to table 3 footnote 1 referrer

Table 3 Footnote 2

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence.

Return to table 3 footnote 2 referrer

Table 3 Footnote 3

There were sales of cannabis oil in Q3 by only one licensed producer. As the data is not aggregate sales from multiple licensed producers, the specific amount of cannabis oil sold is being withheld because it is considered confidential business information.

Return to table 3 footnote 3 referrer

Table 3 Footnote 4

This refers to the amount of cannabis oil produced that was tested, approved, and ready for sale during each quarter (expressed in kg of cannabis oil).

Return to table 3 footnote 4 referrer

Table 3 Footnote 5

Changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence.

Return to table 3 footnote 5 referrer

Table 3 Footnote 6

The Marihuana for Medical Purposes Regulations require that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana ("the equivalency factor"). Information about the equivalency factor is available on each licensed producer's website.

Return to table 3 footnote 6 referrer

MMPR Market Data - Dried Marijuana (2015-2016)

Graph of the data from the preceding table

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. 

MMPR Market Data - Cannabis Oil (2015-2016)Footnote a

Graph of the data from the preceding table

Please note that changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. 

2014 - 2015 Fiscal Year

Market Data: Marijuana for Medical Purposes
  April 1, 2014 to June 30, 2014 (Q1) July 1, 2014 to September 30, 2014 (Q2) October 1, 2014 to December 31, 2014 (Q3) January 1, 2015 to March 31, 2015 (Q4)
Amount of dried marijuana sold to clients (kilograms) 408 596 789 979
Amount of dried marijuana produced during quarter (kilograms)Table 4 Footnote 1 1,020 1,435 1,809 1,618
Amount of dried marijuana for medical purposes in licensed producers' inventories at end of quarter (kilograms)Table 4 Footnote 2 1,134 2,021 2,994 4,667
Average amount of marijuana for medical purposes authorized per client (grams/day) 4 4 4 4
Average amount of marijuana for medical purposes per client shipment (grams/day) 1 1 1 1
Total number of clients registered at end of quarter 7,914 12,409 15,545 18,512
Table 4 Footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana). The amount does not include cannabis oil.

Return to table 4 footnote 1 referrer

Table 4 Footnote 2

Changes in inventories may be a result of amounts of marijuana for medical purposes sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence.

Return to table 4 footnote 2 referrer

MMPR Market Data (2014-2015)

Graph of the data from the first three rows of the preceding table
Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: